Oral liquid compositions of non-steroidal anti-inflammatory drugs
Patent 5183829 Issued on February 2, 1993. Estimated Expiration Date: 
September 27, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
September 27, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesRapid acting combination of sodium sulindac and a base Oral liquid pharmaceutical compositions of sulindac Patent #: 4880835 InventorAssigneeApplicationNo. 766774 filed on 09/27/1991US Classes:514/570, Carboxy or salt thereof only attached indirectly to the benzene ring514/420Indomethacine per se or ester thereofExaminersPrimary: Friedman, S. J.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 031/19A61K 031/40 AbstractPharmaceutically elegant oral compositions of non-steroidal anti-inflammatory drugs or their salts are prepared by adding selected dispersing agents such as a polyvinylpyrrolidone, hydroxypropyl-methylcellulose or hydroxypropylcellulose to the NSAIDs in a medium of polyol-glycol-alcohol. The compositions offer the formation of finely dispersed active ingredients upon dispersion in gastric juice.Other References
| |
